Aurobindo Pharma Issues Nationwide Recall of Migraine Relief Tablets Due to Mislabeling
Aurobindo Pharma USA, Inc. has issued a voluntary nationwide recall of its Healthy Living Migraine Relief tablets due to serious mislabeling issues that could endanger consumer health. Sold primarily through Amazon, these acetaminophen, aspirin, and caffeine tablets lack essential over-the-counter labeling, raising concerns about safe usage. Consumers are urged to check their medicine cabinets and discontinue use if they have purchased the affected product. Stay informed about medication recalls to protect your health.
New Migraine Treatment Atogepant Shows Promise in Reducing Symptoms and Medication Dependence
Recent advancements in migraine treatment highlight atogepant, a CGRP inhibitor, which has shown significant promise in reducing migraine days and reliance on pain medications. A phase 3 trial published in Neurology demonstrated its effectiveness in chronic migraine patients, offering hope for improved quality of life and innovative solutions for migraine management.
Man’s Misdiagnosed Migraine Turns Out to Be Life-Changing Brain Injury
Gurmukh Gahir, also known as Sonny, experienced a misdiagnosed migraine that turned out to be a life-changing brain injury, leaving him with severe cognitive difficulties. The misdiagnosis led to herpes simplex encephalitis, impacting his ability to live and work independently. His family has launched a legal campaign seeking accountability for the misdiagnosis and its devastating consequences.
Woman Nearly Dies After Botox Injections for Migraine Treatment
Alicia Hallock’s harrowing experience with Botox injections for migraines led to her ICU admission. The injections left her partially paralyzed and suffering from dysphagia, requiring a feeding tube for nutrients. Hallock’s recovery journey was shared on social media, emphasizing the severity of her experience with Botox complications.
New Studies Suggest Less Concern for Most Middle-Aged Women Regarding Cardiovascular Risks of Migraines and Menopause Symptoms
Recent studies featured in the journal Menopause suggest that for most middle-aged women, concerns about cardiovascular risks related to migraines, hot flashes, and night sweats may be less significant if they do not experience both migraines and prolonged hot flashes and night sweats. The focus should be on addressing other contributing factors that elevate cardiovascular risk, such as ensuring adequate sleep, engaging in regular exercise, adopting a healthy diet, quitting smoking, and managing blood pressure, blood sugar, cholesterol, and weight. The research, based on a long-term study involving over 1,900 women, offers valuable insights into health patterns during menopause.